Article
Laminin γ2–mediating T cell exclusion attenuates response to anti–PD-1 therapy
3 Feb 2021
Abstract excerpt
PD-1/PD-L1 blockade therapies provide notable clinical benefits for patients with advanced cancers, but the factors influencing the effectiveness of the treatment remain incompletely cataloged. Here, the up-regulation of laminin γ2 (Ln-γ2) predicted the attenuated efficacy of anti-PD-1 drugs and was associated with unfavorable outcomes in patients with lung cancer or esophageal cancer. Furthermore, Ln-γ2 was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
